Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice

Neuropharmacology

Volumn 37, Issue 9, 1998, Pages 1123-1130

  Paton, Gaynor S ^a   Pertwee, Roger G ^a   Davies, Stephen N ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Aminobutyric acid; Cannabinoids; Paired pulse depression; SR141716A; WIN55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID; CANNABINOID RECEPTOR; RIMONABANT;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; GABAERGIC SYSTEM; HIPPOCAMPUS; IN VITRO STUDY; LONG TERM POTENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; ELECTRIC STIMULATION; EVOKED POTENTIALS; FEMALE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG;

EID: 0032428211     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00096-3     Document Type: Article

References (35)

1. Anderson, L.A., Anderson, J.J., Chase, T.N., Walters, J.R., 1995. The cannabinoid agonist WIN55212-2 and CP55940 attenuate rotational behaviour induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Brain Res. 691, 106-114.
2. Anderson, W.W., Collingridge, G.L., 1997. A data acquistion program for on-line analysis of long-term potentiation and longterm depression. Neurosci. Abst. 23, 665.
3. Banerjee, S.P., Snyder, S.H., Mechoulam, R., 1975. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. J. Pharmacol. Exp. Ther. 194, 74-81.
4. Bidaut-Russell, M., Devane, W.A., Howlett, A.C., 1990. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem. 55, 21-26.
5. Bordi, F., Reggiani, A., Conquet, F., 1997. Regulation of synaptic plasticity by mGluR1 mutant mice. Brain Res. 761, 121-126.
6. Bouaboula, M., Perrachon, S., Milligan, L., et al., 1997. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by Insulin or Insulin-like growth factor 1. J. Biol. Chem. 272, 22330-22339.
7. Brown, R.E. and, Reymann, K.G., 1995. Metabotropic glutamate receptor agonists reduce paired pulse depression in the dentate gyrus of the rat in vitro. Neurosci. Lett. 196, 17-20.
8. Collins, D.R., Pertwee, R.G., Davies, S.N., 1994. The actions of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur. J. Pharmacol. 259, R7-R8.
9. Collins, D.R., Pertwee, R.G., Davies, S.N., 1995. Prevention by the cannabinoid antagonist, SR141716A of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol. 115, 869-870.
10. 9-tetrahydrocannabinol on GABAA receptor-mediated responses in a grease-gap recording preparation of the rat hippocampal slice. Neuropharmacology 36, 1387-1392.
11. Debanne, D., Guérineau, N.C., Gähwiler, B.H., Thompson, S.M., 1996. Paired pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J. Physiol. 491, 163-176.
12. Douglas, R.M., Goddard, G.V., Riives, M., 1982. Inhibitory modulation of long-term potentiation: evidence for a postsynaptic locus of control. Brain Res. 240, 259-272.
13. Glass, M., Brotchie, J.M., Maneuf, Y.P., 1997. Modulation of neurotransmission by cannabinoids in the basal ganglia. Eur. J. Neurosci. 9, 199-203.
14. Hershkowitz, M., Goldman, R., Raz, A., 1977. Effect of cannabinoids on neurotransmitter uptake ATPase activity and morphology of mouse brain synaptosomes. Biochem. Pharmacol. 26, 1327-1331.
15. Katz, B., Miledi, R., 1969. The role of calcium in neuromuscular facilitation. J. Physiol. 195, 481-492.
16. Landsman, R.S., Burkey, T.H., Consroe, P., Roeske, W.R., Yamamura, H.I., 1997. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur. J. Pharmacol. 334, R1-R2.
17. Mackie, K., Hillie, B., 1992. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825-3829.
18. Maneuf, Y.P., Brotchie, J.M., 1995. Modulation of gamma-aminobutyric acid (GABA) uptake by cannabinoids and protein kinases in the globus pallidus. Brain Res. Assoc. Abst. 12 (25), 5.
19. Maneuf, Y.P., Crossman, A.R., Brotchie, J.M., 1996. Modultaion on GABA-ergic transmission in the globus pallidus by the synthetic cannanbinoid WIN55212-2. Synapse 22, 382-385.
20. Munro, S., Thomas, K.L., Abu-Shaar, M., 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
21. Nowicky, A.V., Teyler, T.J., Vardaris, R.M., 1987. The modulation of LTP by delta-9-THC in the rat hippocampus in vitro. Brain Res. 19, 663-672.
22. Pertwee, R.G., Greentree, S.G., 1988. Delta-9-tetrahydrocannabinol induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropharmacology 27, 485-491.
23. Pertwee, R.G., Greentree, S.G., Swift, P.A., 1988. Drugs which stimulate or facilitate central GABA-ergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology 27, 1265-1270.
24. Pertwee, R.G., Stevenson, L.A., Elrick, D.B., Mechoulam, R., Corbett, A.D., 1992. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharm. 105, 980-984.
25. Pertwee, R.G., Wickens, A.P., 1991. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology 30, 237-244.
26. Pin, J.P., Duvoisin, R., 1995. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34, 1-26.
27. Rinaldi-Carmona, M., Barth, F., Héaulme, M., et al., 1994. SR141716A a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
28. Scanziani, M., Salin, P.A., Vogt, K.E., Malenka, R.C., Nicoll, R.A., 1997. Use dependent increases in glutamate concentration activates presynaptic metabotropic glutamate receptors. Nature 385, 630-634.
29. Schwartzkroin, P.A., Knowles, W.D., 1983. Local interactions in the hippocampus. Trends Neurosci. 6, 88-92.
30. Shen, M., Piser, T.M., Thayer, S.A., 1996. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16, 4322-4334.
31. Showalter, V.M., Compton, D.R., Martin, B.R., Abood, M.E., 1996. J. Pharmacol. Exp. Ther. 278, 989-999.
32. Terranova, J.P., Michaud, J.C., Le Fur, G., Soubrié, P., 1995. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 576-579.
33. Vardaris, R.M., Weisz, D.J., Teyler, T.J., 1977. Delta-9-tetrahydrocannabinol and the hippocampus: effects on CA1 field potentials in rats. Brain Res. Bull. 2, 181-187.
34. Weisz, D.J., Gunnell, D.L., Teyler, T.J. and, Vardaris, R.M., 1982. Changes in hippocampal CA1 population spikes following administration of delta-9-THC. Brain Res.Bull. 8, 155-162.
35. Wickens, A.P., Pertwee, R.G., 1993. Delta-9-tetrahydrocannabinol and anadamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. Eur. J. Pharm. 250, 205-208.